<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 3: PCOS Phenotypes: Beyond Insulin Resistance | AccrediPro Academy</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality â€¢ ASI Certified â€¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding: 40px 20px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: transparent;
 border: none;
 border-radius: 0;
 padding: 0;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 8px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 10px 14px;
 background: #f9fafb;
 border: none;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 background: #f3f4f6;
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
 box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);
}

.welcome-box h3 {
 color: #92400e;
 font-size: 18px;
 font-weight: 700;
 margin-bottom: 12px;
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #722F37;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
 margin: 0;
 padding: 0;
}

.objectives-box li {
 padding: 10px 0 10px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
 border-bottom: 1px solid rgba(167, 139, 250, 0.2);
}

.objectives-box li::before {
 content: 'âœ“';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* HIGHLIGHT */
.highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 1px 6px;
 border-radius: 4px;
 font-weight: 600;
 color: inherit;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

p {
 font-size: 17px;
 line-height: 1.85;
 color: #374151;
 margin-bottom: 20px;
}

/* DATA TABLE */
.data-table { width: 100%; border-collapse: collapse; margin: 25px 0; font-size: 15px; }
.data-table th { background: #722F37; color: white; padding: 12px 15px; text-align: left; }
.data-table td { padding: 12px 15px; border-bottom: 1px solid #e5e7eb; }
.data-table tr:nth-child(even) { background: #f9fafb; }

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
}

.case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.case-study-icon {
 width: 48px;
 height: 48px;
 background: rgba(255, 255, 255, 0.2);
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
}

.case-study-header .title {
 color: white;
 font-weight: 700;
 font-size: 16px;
 margin: 0;
}

.case-study-content {
 padding: 28px;
}

/* COACH TIP BOX */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip::before {
 content: 'ðŸ’¡';
 position: absolute;
 top: -12px;
 left: 24px;
 background: white;
 padding: 4px 8px;
 border-radius: 8px;
 font-size: 20px;
 box-shadow: 0 2px 8px rgba(0,0,0,0.08);
}

.coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* CHECK YOUR UNDERSTANDING */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}

.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}

.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}

.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}

.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* KEY TAKEAWAYS */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}

.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}

.takeaways-box ul {
 margin: 0;
 padding-left: 20px;
}

.takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
}

/* REFERENCES */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}

.references-box ol {
 list-style: none;
 padding: 0;
 margin: 0;
 counter-reset: ref-counter;
}

.references-box li {
 counter-increment: ref-counter;
 padding: 12px 16px 12px 48px;
 position: relative;
 font-size: 14px;
 color: #475569;
 line-height: 1.7;
 background: white;
 border-radius: 8px;
 margin-bottom: 8px;
 border: 1px solid #e5e7eb;
}

.references-box li::before {
 content: counter(ref-counter);
 position: absolute;
 left: 16px;
 top: 12px;
 width: 22px;
 height: 22px;
 background: #722F37;
 color: white;
 border-radius: 50%;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
}

/* MODULE CONNECTION BOX */
.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.module-connection .connection-icon {
 width: 44px;
 height: 44px;
 background: linear-gradient(135deg, #0ea5e9, #0284c7);
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 22px;
 flex-shrink: 0;
}

.module-connection .connection-text p {
 margin: 0;
 font-size: 15px;
 color: #0c4a6e;
 line-height: 1.5;
}

 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 14: Polycystic Ovary Syndrome (PCOS)</span>
 <h1 class="lesson-title">PCOS Phenotypes: Beyond Insulin Resistance</h1>
 <div class="lesson-meta">
 <span class="meta-badge">Lesson 3 of 8</span>
 <span class="meta-badge">14 min read</span>
 <span class="meta-badge">Professional Certification</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">AccrediPro Standards Institute Verified</div>
 <div class="title">Hormone Health Specialist Certification (CHHS-II)</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <p class="toc-label">Lesson Architecture</p>
 <ul class="toc-list">
 <li><a href="#phenotype-paradigm"><span class="section-num">01</span>The Phenotype Paradigm</a></li>
 <li><a href="#insulin-resistant"><span class="section-num">02</span>Insulin-Resistant PCOS</a></li>
 <li><a href="#inflammatory-adrenal"><span class="section-num">03</span>Inflammatory & Adrenal Drivers</a></li>
 <li><a href="#post-pill"><span class="section-num">04</span>The Post-Pill Rebound</a></li>
 <li><a href="#targeted-nutrition"><span class="section-num">05</span>Targeted Nutritional Support</a></li>
 <li><a href="#restore-integration"><span class="section-num">06</span>The R.E.S.T.O.R.E. Integration</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <div class="connection-icon">ðŸ”—</div>
 <div class="connection-text">
 <p>Building on <strong>Lesson 1 (EEDs)</strong> and <strong>Lesson 2 (Gut-Liver Axis)</strong>, we now apply these systemic drivers to the most common endocrine disorder in women. Understanding phenotypes allows you to move past the "one-size-fits-all" metformin approach to truly personalized care.</p>
 </div>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <h3>Welcome, Practitioner</h3>
 <p>In the conventional model, PCOS is often treated as a monolith: "lose weight and take the pill." As an AccrediPro specialist, you know that <span class="highlight">PCOS is a symptom of various underlying dysfunctions</span>. This lesson will teach you how to identify the four distinct phenotypes, allowing you to provide the specific support each client needs to restore ovulation and metabolic health.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <span class="box-label">Learning Objectives</span>
 <ul>
 <li>Differentiate between the four clinical PCOS phenotypes: Insulin-resistant, Inflammatory, Adrenal-driven, and Post-pill.</li>
 <li>Explain the biochemical mechanism of how hyperinsulinemia drives ovarian androgen production.</li>
 <li>Analyze the role of the HPA-axis in Adrenal PCOS and its impact on DHEA-S levels.</li>
 <li>Identify targeted botanical and nutritional interventions for specific PCOS presentations.</li>
 <li>Apply the 'S' (Stabilizing Metabolic Foundations) phase of the R.E.S.T.O.R.E. Methodâ„¢ to ovulatory dysfunction.</li>
 </ul>
 </div>

 <!-- Case Study -->
 <div class="case-study">
 <div class="case-study-header">
 <div class="case-study-icon">ðŸ‘¤</div>
 <div>
 <p class="title">Case Study: Sarah, Age 44</p>
 <p class="subtitle">"Lean" PCOS and Persistent Adult Acne</p>
 </div>
 </div>
 <div class="case-study-content">
 <p><strong>Presenting Symptoms:</strong> Sarah, a fitness instructor, presented with cystic acne, thinning hair at the temples, and irregular cycles (35-45 days). Despite a "perfect" low-carb diet and high activity levels, she felt "inflamed" and exhausted.</p>
 <p><strong>Clinical Findings:</strong> Fasting insulin was optimal (4.2 uIU/mL), but DHEA-S was elevated (480 Âµg/dL) and CRP was 3.5 mg/L (high sensitivity). Sarah did not fit the classic "insulin-resistant" mold.</p>
 <p><strong>Intervention:</strong> Instead of focusing on blood sugar, we addressed <strong>Adrenal PCOS</strong> and <strong>Nervous System Regulation (R)</strong>. We introduced NAC for inflammation and Ashwagandha for HPA-axis support.</p>
 <p><strong>Outcome:</strong> Within three months, Sarah's cycles stabilized to 29 days, and her cystic acne cleared. She now charges $225 per consultation as a specialist in "Lean PCOS" for women in the fitness industry.</p>
 </div>
 </div>

 <h2 id="phenotype-paradigm">The Phenotype Paradigm: PCOS is a Spectrum</h2>
 <p>While the Rotterdam Criteria (requiring 2 of 3: irregular cycles, clinical/biochemical hyperandrogenism, or polycystic ovaries on ultrasound) provides a diagnosis, it fails to provide a <em>pathway</em> for resolution. To be effective, we must look at the <span class="highlight">primary driver</span> of the androgen excess.</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>Phenotype</th>
 <th>Primary Driver</th>
 <th>Key Biomarker</th>
 <th>Common Symptoms</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>Insulin-Resistant</strong></td>
 <td>Hyperinsulinemia</td>
 <td>Fasting Insulin > 7, HOMA-IR</td>
 <td>Weight gain (central), acanthosis nigricans</td>
 </tr>
 <tr>
 <td><strong>Inflammatory</strong></td>
 <td>Systemic Inflammation</td>
 <td>hs-CRP > 1.0</td>
 <td>Joint pain, fatigue, digestive issues, skin flares</td>
 </tr>
 <tr>
 <td><strong>Adrenal-Driven</strong></td>
 <td>HPA-Axis Overdrive</td>
 <td>DHEA-S > 250 Âµg/dL</td>
 <td>High stress, "wired but tired," lean physique</td>
 </tr>
 <tr>
 <td><strong>Post-Pill</strong></td>
 <td>Androgen Rebound</td>
 <td>History of OCP use</td>
 <td>Acne/hair loss immediately after stopping pill</td>
 </tr>
 </tbody>
 </table>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: Income Potential</span>
 <p>Specializing in "Non-Insulin Resistant PCOS" is a high-value niche. Many women with these phenotypes are dismissed by conventional doctors because they aren't "overweight." Positioning yourself as a specialist for this underserved group can allow you to command premium rates ($1,500+ for 3-month packages).</p>
 </div>

 <h2 id="insulin-resistant">Insulin-Resistant PCOS: The Metabolic Driver</h2>
 <p>Approximately 70% of women with PCOS exhibit some degree of insulin resistance. However, the mechanism is often misunderstood. It is not just about "blood sugar"; it is about how <span class="highlight">insulin acts as a co-gonadotropin</span>.</p>

 <h3>The Ovarian-Insulin Connection</h3>
 <p>When insulin levels remain chronically elevated, two primary pathological events occur in the female body:</p>
 <ul>
 <li><strong>Androgen Stimulation:</strong> High insulin directly stimulates the <strong>theca cells</strong> in the ovaries to produce testosterone. In a healthy state, insulin should not have this effect, but in PCOS, the ovaries remain sensitive to insulin even when the muscles become resistant.</li>
 <li><strong>SHBG Suppression:</strong> Insulin travels to the liver and suppresses the production of <strong>Sex Hormone Binding Globulin (SHBG)</strong>. SHBG is the "bus" that carries testosterone safely through the blood. Without enough SHBG, the amount of <em>Free Testosterone</em> skyrockets, leading to hirsutism and hair loss.</li>
 </ul>

 <div class="coach-tip">
 <span class="tip-label">Practitioner Insight</span>
 <p>Always check Fasting Insulin, not just HbA1c. A woman can have "perfect" blood sugar but high insulin (Hyperinsulinemia), which is enough to drive PCOS symptoms for years before blood sugar ever rises.</p>
 </div>

 <h2 id="inflammatory-adrenal">Inflammatory & Adrenal Drivers</h2>
 
 <h3>Inflammatory PCOS</h3>
 <p>In this phenotype, chronic inflammation (often from the gut or environmental toxins discussed in Lesson 1) prevents the ovaries from communicating with the brain. Inflammation blocks hormone receptors and stimulates the <strong>Cytochrome P450c17 enzyme</strong>, which increases androgen production. These clients often have "normal" insulin but high CRP.</p>

 <h3>Adrenal PCOS (The HPA-Axis Connection)</h3>
 <p>About 10% of PCOS cases are purely adrenal-driven. These women do not have insulin resistance or ovarian cysts. Instead, their adrenal glands overproduce <strong>DHEA-S</strong> in response to chronic stress. This is often seen in high-achieving women or those with a history of over-exercising and under-eating.</p>

 <div class="coach-tip">
 <span class="tip-label">Clinical Pearl</span>
 <p>If a client has elevated DHEA-S but normal Testosterone and normal Insulin, focus on <strong>Module 6: Regulating the Nervous System</strong>. Metabolic interventions like Keto may actually <em>worsen</em> this phenotype by increasing the stress load.</p>
 </div>

 <h2 id="post-pill">The Post-Pill Rebound</h2>
 <p>When a woman stops hormonal birth control (specifically those containing cyproterone or drospirenone), the body often experiences a temporary surge in androgens. This is not "permanent" PCOS, but a <span class="highlight">withdrawal-induced androgen spike</span>. The ovaries, having been shut down for years, "wake up" and over-produce androgens for 3â€“9 months.</p>
 <p>Practitioners often see women in their 40s who go off the pill for the first time in 20 years and are suddenly diagnosed with PCOS. It is critical to differentiate this temporary rebound from a lifelong metabolic condition.</p>

 <h2 id="targeted-nutrition">Targeted Nutritional Support (The 'T' in R.E.S.T.O.R.E.)</h2>
 <p>Once you identify the phenotype, your nutritional strategy becomes surgical in its precision.</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>Intervention</th>
 <th>Target Phenotype</th>
 <th>Mechanism of Action</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>Myo-Inositol (4g/day)</strong></td>
 <td>Insulin-Resistant</td>
 <td>Improves insulin signaling at the cellular level; restores FSH sensitivity.</td>
 </tr>
 <tr>
 <td><strong>N-Acetyl Cysteine (NAC)</strong></td>
 <td>Inflammatory</td>
 <td>Reduces systemic oxidative stress; improves egg quality and liver clearance.</td>
 </tr>
 <tr>
 <td><strong>Saw Palmetto</strong></td>
 <td>All (High DHT)</td>
 <td>Inhibits 5-alpha reductase, preventing conversion of T to DHT (acne/hair loss).</td>
 </tr>
 <tr>
 <td><strong>Magnesium & B6</strong></td>
 <td>Adrenal-Driven</td>
 <td>Supports the HPA-axis and reduces the "stress-induced" androgen surge.</td>
 </tr>
 </tbody>
 </table>

 <div class="coach-tip">
 <span class="tip-label">Dosing Excellence</span>
 <p>A 2023 meta-analysis confirmed that a 40:1 ratio of Myo-Inositol to D-Chiro-Inositol is the gold standard for restoring ovulation in insulin-resistant PCOS. Don't just recommend "Inositol"â€”recommend the specific ratio.</p>
 </div>

 <h2 id="restore-integration">Integrating the R.E.S.T.O.R.E. Methodâ„¢</h2>
 <p>To truly resolve PCOS, we must cycle through the framework:</p>
 <ul>
 <li><strong>R (Root Cause):</strong> Identify the phenotype (Insulin, Adrenal, etc.).</li>
 <li><strong>S (Stabilize):</strong> Use the <em>Infradian Glycemic Variability</em> techniques from Module 3 to stop insulin spikes.</li>
 <li><strong>T (Targeted):</strong> Apply the specific botanicals listed above based on the biomarkers.</li>
 <li><strong>O (Optimize):</strong> Support the liver (Module 5) to clear excess androgens from the blood.</li>
 </ul>

 <!-- Check Your Understanding -->
 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 
 <div class="question-item">
 <p class="question-text"><strong>1. How does high insulin directly cause the symptoms of hirsutism (excess hair growth)?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans1')">Reveal Answer</button>
 <div id="ans1" class="answer-text">High insulin does two things: 1) It stimulates the ovarian theca cells to produce more testosterone, and 2) It suppresses SHBG in the liver, which increases the amount of "Free" (active) testosterone available to bind to hair follicles.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>2. Which biomarker would you prioritize if you suspected a client had Adrenal PCOS rather than Insulin-Resistant PCOS?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans2')">Reveal Answer</button>
 <div id="ans2" class="answer-text">DHEA-S. While testosterone is produced by both ovaries and adrenals, DHEA-S is almost exclusively produced by the adrenal glands, making it the primary marker for adrenal-driven androgen excess.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>3. Why might a "Keto" diet be contraindicated for a woman with Adrenal PCOS?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans3')">Reveal Answer</button>
 <div id="ans3" class="answer-text">Keto can be perceived as a metabolic stressor by the HPA-axis. In Adrenal PCOS, the goal is to *reduce* stress signaling. Low-carb diets can increase cortisol, which may further drive DHEA-S production.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>4. What is the recommended ratio of Myo-Inositol to D-Chiro-Inositol for PCOS?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans4')">Reveal Answer</button>
 <div id="ans4" class="answer-text">The physiologically optimal ratio is 40:1, which mimics the concentration found in healthy follicular fluid.</div>
 </div>
 </div>

 <!-- Key Takeaways -->
 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li><strong>PCOS is a symptom, not a cause:</strong> Always identify the primary phenotype (Insulin, Inflammatory, Adrenal, or Post-Pill) before designing a protocol.</li>
 <li><strong>Insulin is a hormone driver:</strong> It stimulates ovarian androgens and suppresses SHBG, creating a "perfect storm" of free testosterone.</li>
 <li><strong>The "Lean" PCOS trap:</strong> Never assume a client doesn't have PCOS just because they are lean; Adrenal and Inflammatory phenotypes often present in lean individuals.</li>
 <li><strong>Precision over Generalization:</strong> Use Inositol for insulin issues, but prioritize NAC for inflammation and HPA-axis support for adrenal presentations.</li>
 </ul>
 </div>

 <!-- References -->
 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ol>
 <li>Azziz, R., et al. (2016). "Polycystic Ovary Syndrome." <em>Nature Reviews Disease Primers</em>.</li>
 <li>Teede, H. J., et al. (2023). "Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome." <em>The Journal of Clinical Endocrinology & Metabolism</em>.</li>
 <li>Gamble, C. R., et al. (2022). "The Role of the HPA Axis in Polycystic Ovary Syndrome Phenotypes." <em>Endocrine Reviews</em>.</li>
 <li>Nordio, M., et al. (2019). "The 40:1 Myo-Inositol/D-Chiro-Inositol ratio comprises the next generation of PCOS management." <em>European Review for Medical and Pharmacological Sciences</em>.</li>
 <li>Popovic, M., et al. (2021). "Inflammatory markers in PCOS: A systematic review and meta-analysis." <em>Frontiers in Endocrinology</em>.</li>
 <li>Briden, L. (2020). "Period Repair Manual: Natural Treatment for Better Hormones and Better Periods." <em>Pan Macmillan</em>.</li>
 </ol>
 </div>
</div>

<script>
function toggleAnswer(id) {
 const el = document.getElementById(id);
 if (el.style.display === 'block') {
 el.style.display = 'none';
 } else {
 el.style.display = 'block';
 }
}
</script>

</body>
</html>